Note that some links may require registration or subscription.
The Supreme Court said the Biden administration can temporarily continue to request removal of misleading content, like medical misinformation, from social media companies. (Washington Post)
The FDA approved the meningococcal groups A, B, C, W and Y vaccine (Penbraya), which provides the broadest coverage yet for meningococcal serogroups common to young adults, Pfizer announced.
An AP visual analysis suggested the explosion at Gaza’s al-Ahli Arab Hospital was likely caused by a malfunctioning rocket fired from within Palestinian territory.
As bombardments in Gaza continue, hospital workers care for gravely injured patients in untenable conditions and families face impossible choices about where to go. (Washington Post)
Researchers are paying more attention to potential ties between long COVID and menopause. (STAT)
The FDA extended the shelf life of certain lots of monoclonal antibody vilobelimab (Gohibic), used to treat COVID-19 in some hospitalized adults, from 24 months to 30 months.
The agency also approved a topical acne gel that combines clindamycin phosphate, adapalene, and benzoyl peroxide (Cabtreo), Bausch Health said.
Leishmania, a disease-causing parasite capable of causing a disfiguring skin disease, may now be endemic to Texas. (NBC News)
One month after a pig heart transplant, the man who received it is recovering with physical therapy. (AP)
The FDA granted accelerated approval to Genentech’s entrectinib (Rozlytrek) for patients older than 1 month with certain kinds of solid tumors.
The agency also expanded the indication for vosoritide (Voxzogo) for achondroplasia with open epiphyses to include children of all ages, BioMarin said.
Law enforcement and public health officials say a surge in counterfeit versions of weight loss drugs like semaglutide (Ozempic) may be the worst since counterfeit erectile dysfunction drugs. (Reuters)
People who weigh more are likely to metabolize drugs differently and may be getting the wrong doses of numerous medications. (USA Today)
Fortress Safe is recalling more than 60,000 potentially faulty gun safes following the death of a child who accessed a gun from a safe in his home. (New York Times)
Philips Respironics is voluntarily recalling its V60 Ventilators and V60 Plus Ventilators due to a problem that can cause power failure, loss of ventilator function, and death, the FDA announced.
Allegations of bullying have surfaced around a prominent Johns Hopkins Hospital pathologist who recently went on administrative leave after a misdiagnosis. (Washington Post)
The National Association of County & City Health Officials alerted the White House of a shortage in Pfizer’s penicillin G Benzathine (Bicillin L-A), used to treat syphilis.
Johnson & Johnson announced significant skin clearance across all skin tones in a phase III trial for plaque psoriasis injectable drug guselkumab (Tremfya).
The company also said its phase II study of the oral compound JNJ-1802 showed antiviral activity against dengue in humans, the first to do so in a clinical trial.